Pregled bibliografske jedinice broj: 316893
Retrospective study of specific immunotherapy - what should be done in the future
Retrospective study of specific immunotherapy - what should be done in the future // Acta Dermatovenerologica Croatica, 15 (2007), 4; 221-227 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 316893 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Retrospective study of specific immunotherapy - what should be done in the future
Autori
Milavec-Puretić, Višnja ; Lipozenčić, Jasna ; Ledić-Drvar, Danijela, Šmigovec, Eva ; Milavec, Dinko
Izvornik
Acta Dermatovenerologica Croatica (1330-027X) 15
(2007), 4;
221-227
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
airborne allergens; atopic dermatitis; specific immunotherapy
Sažetak
In this retrospective study, data on 241 atopic patients treated with specific cutaneous immunotherapy during the 1985-2006 period at Allergy Clinic, University Department of Dermatology and Venereology, were reviewed. The following diagnoses were recorded: and Venereology atopic dermatitis, pure or in combination with allergic rhinitis or Zagreb University Hospital Center allergic bronchitis, or allergic bronchitis and asthma, allergic rhinitis, allergic conjunctivitis, urticaria, and Quincke’ s edema. The aim was to retrospectively analyze clinical efficacy and laboratory findings in atopic patients undergoing specific immunotherapy. Before specific HR-10000 Zagreb immunotherapy administration, eosinophil count, immunoglobulins, skin prick test, total IgE (RIST) and specific IgE (IgE UniCAP) were determined. The following allergens were included in specific immunotherapy: Dermatophagoides pteronyssinus, house dust mite (mixed or separately), mixed and single pollens (grass, tree, weed), feather, and animal dander. The most frequent allergens in 241 atopic patients were grass pollen mixture, Dermatophagoides pteronyssinus, ragweed, tree pollen mixture, cocksfoot, birch, animal dander, and feather. Treatment efficacy was demonstrated after 3 years of continuous therapy by clinical evaluation and with the same diagnostic procedure. After several months of therapy, initial clinical improvement was noticed in atopic dermatitis patients as well as in patients with respiratory diseases that were sensitive to airborne allergens. According to literature, specific immunotherapy was used as a treatment option, which may affect the natural course of allergic diseases. It reduces development of asthma in patients with allergic rhinitis and prevents the onset of new sensitizations.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0108166
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- MEDLINE
- Chemical Abstracts
- Excerpta Medica
- Index Medicus
- SCIE